Drug intelligence / Profile preview

Shuiguitie

Development stage: Unknown
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Shuiguitie is a topical Traditional Chinese Medicine (TCM) currently under clinical investigation for the treatment of cirrhosis with refractory ascites. It is being studied in combination with tolvaptan. Developed by institutions focused on Traditional Chinese Medicine, its therapeutic approach is rooted in TCM principles, which often involve holistic treatment and herbal formulations applied externally.

Other names: 水臌贴

Beyond the preview

Go deeper on Shuiguitie.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuiguitie.

Explore the full profile